These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9273430)

  • 21. Hormones and pregnancy: thromboembolic risks for women.
    Kujovich JL
    Br J Haematol; 2004 Aug; 126(4):443-54. PubMed ID: 15287937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Summaries for patients. Postmenopausal hormone replacement therapy to prevent chronic conditions: recommendations from the U.S. Preventive Services Task Force.
    U.S. Preventive Services Task Force
    Ann Intern Med; 2002 Nov; 137(10):I48. PubMed ID: 12435233
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hormone therapy and cardiovascular risk].
    Wütschert R; Cirafici P
    Praxis (Bern 1994); 2000 Jun; 89(25-26):1090-7. PubMed ID: 11367591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombophilic profile of climacteric and menopausal women with venous thromboembolism.
    Margarido PF; D'Amico E; Bagnoli VR; Fonseca AM; Halbe HW; Pinotti JA
    Climacteric; 2002 Mar; 5(1):87-9. PubMed ID: 11974563
    [No Abstract]   [Full Text] [Related]  

  • 25. Venous thrombosis and conjugated equine estrogen in women without a uterus.
    Curb JD; Prentice RL; Bray PF; Langer RD; Van Horn L; Barnabei VM; Bloch MJ; Cyr MG; Gass M; Lepine L; Rodabough RJ; Sidney S; Uwaifo GI; Rosendaal FR
    Arch Intern Med; 2006 Apr; 166(7):772-80. PubMed ID: 16606815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormone replacement therapy and ischaemic heart disease: continuing questions but still no answers.
    Lloyd G
    Int J Clin Pract; 2000 Sep; 54(7):416-7. PubMed ID: 11070562
    [No Abstract]   [Full Text] [Related]  

  • 27. Common risk factors for both arterial and venous thrombosis.
    Lowe GD
    Br J Haematol; 2008 Mar; 140(5):488-95. PubMed ID: 18275426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hormone replacement in patients at high risk for thromboses].
    Hiller F
    Internist (Berl); 1997 Oct; 38(10):999-1000. PubMed ID: 9432514
    [No Abstract]   [Full Text] [Related]  

  • 29. Hormone replacement therapy: to use or not to use?
    Baber RJ; O'Hara JL; Boyle FM
    Med J Aust; 2003 Jun; 178(12):630-3. PubMed ID: 12797851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HRT and cardiovascular disease.
    Meade TW; Vickers MR
    J Epidemiol Biostat; 1999; 4(3):165-90. PubMed ID: 10695958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.
    Canonico M; Olié V; Carcaillon L; Tubert-Bitter P; Scarabin PY;
    Thromb Haemost; 2008 Jan; 99(1):246-8. PubMed ID: 18217166
    [No Abstract]   [Full Text] [Related]  

  • 32. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
    Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hormone replacement therapy and venous thromboembolism].
    Trillot N; Susen S; Jude B
    Gynecol Obstet Fertil; 2004 Sep; 32(9):725-8. PubMed ID: 15380753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Estrogen and thrombosis].
    Haase Moen M
    Tidsskr Nor Laegeforen; 1998 Nov; 118(29):4561-2. PubMed ID: 9889647
    [No Abstract]   [Full Text] [Related]  

  • 35. [Alarming data on the risk of breast cancer following estrogen replacement therapy should be interpreted carefully].
    Odlind V
    Lakartidningen; 2005 Apr 18-24; 102(16):1217-8. PubMed ID: 15921094
    [No Abstract]   [Full Text] [Related]  

  • 36. Estrogen therapy and thrombotic risk.
    Miller VM; Jayachandran M; Heit JA; Owen WG
    Pharmacol Ther; 2006 Sep; 111(3):792-807. PubMed ID: 16473411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hormonal replacement therapy in menopause and cancer risk. An update].
    La Vecchia C; Franceschi S
    Minerva Ginecol; 2003 Jun; 55(3):217-9. PubMed ID: 14581867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The hormone replacement therapy conundrum.
    Abushama MD; Ahmed BI
    Saudi Med J; 2003 Mar; 24(3):243-4. PubMed ID: 12704496
    [No Abstract]   [Full Text] [Related]  

  • 39. Long-term use of estrogen-only hormone replacement therapy (HRT) linked with increased risk of ovarian cancer.
    American Medical Association
    Ginecol Obstet Mex; 2002 Aug; 70():409-10. PubMed ID: 12448047
    [No Abstract]   [Full Text] [Related]  

  • 40. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.